default search action

combined dblp search
author search
venue search
publication search

ask others

Michael Takla

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

Journal Articles

see FAQ

What is the meaning of the colors in the publication lists?

2022
[j1]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/cmpb/RombergSJKWGSTH22
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cmpb/RombergSJKWGSTH22
Daniel Romberg, Klaus Strohmenger, Christoph Jansen, Tobias Küster, Nick Weiss, Christian Geißler, Tomasz Soltysinski, Michael Takla, Peter Hufnagl, Norman Zerbe, André Homeyer:
EMPAIA App Interface: An open and vendor-neutral interface for AI applications in pathology. Comput. Methods Programs Biomed. 215: 106596 (2022)

Informal and Other Publications

see FAQ

What is the meaning of the colors in the publication lists?

2024
[i1]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/corr/abs-2401-09450
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/corr/abs-2401-09450
Norman Zerbe, Lars Ole Schwen, Christian Geißler, Katja Wiesemann, Tom Bisson, Peter Boor, Rita Carvalho, Michael Franz, Christoph Jansen, Tim-Rasmus Kiehl, Björn Lindequist, Nora Charlotte Pohlan, Sarah Schmell, Klaus Strohmenger, Falk Zakrzewski, Markus Plass, Michael Takla, Tobias Küster, André Homeyer, Peter Hufnagl:
Joining Forces for Pathology Diagnostics with AI Assistance: The EMPAIA Initiative. CoRR abs/2401.09450 (2024)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.